Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
eurovet-ah.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Valuation

$0000 

Revenue

$0000 

About Eurovet Animal Health

Eurovet Animal Health is the pharmaceutical division of A.U.V. Holding. The Netherlands-based business operates in the companion animal pharmaceuticals and farm animal pharmaceuticals markets.In April 2012, Eurovet Animal Health was acquired by Dechra Pharmaceuticals. The valuation of Eurovet Animal Health was $176.4 million. Other terms of the deal were not released.

Eurovet Animal Health Headquarter Location

Handelsweg 25

5531 AE,

Netherlands

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Eurovet Animal Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Eurovet Animal Health is included in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Eurovet Animal Health Patents

Eurovet Animal Health has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/16/2010

3/25/2014

Xanthines, Lactams, Adenosine receptor antagonists, Designer drugs, Nitriles

Grant

Application Date

12/16/2010

Grant Date

3/25/2014

Title

Related Topics

Xanthines, Lactams, Adenosine receptor antagonists, Designer drugs, Nitriles

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.